Gazyva
FDA Grants Accelerated Approval to Brukinsa for Relapsed or Refractory Follicular Lymphoma
The FDA granted accelerated approval to Brukinsa with Gazyva for relapsed or refractory follicular lymphoma after ...
MARCH 9, 2024
FDA Approves Imbruvica With Gazyva for First-Line CLL Treatment
The FDA expanded the labeling for Imbruvicato include use with Gazyva in treatment-naive patients with chronic ...
FEBRUARY 4, 2019
FDA Approves Gazyva for Previously Untreated Advanced FL
The FDA granted regular approval to obinutuzumab (Gazyva, Genentech) for use in treatment-naive adults with stage ...
NOVEMBER 21, 2017
Load more